• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 4th January 2018

OHE at HESG Winter 2018

A summary of OHE’s activity at the 2018 winter HESG meeting, City, University of London, 10-12th January. OHE team members will play an active role in the forthcoming Health Economists’ Study Group (HESG) Meeting, City, University of London, 10-12th January…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

A summary of OHE’s activity at the 2018 winter HESG meeting, City, University of London, 10-12th January.

OHE team members will play an active role in the forthcoming Health Economists’ Study Group (HESG) Meeting, City, University of London, 10-12th January 2018. We have one paper being discussed and will be discussing others’ papers and chairing sessions. Members of the OHE team will also be available to answer questions about the wider OHE research programme.

OHE work being discussed:

Re-modelling the UK EQ-5D-3L Value Set
Authors: Yan Feng, Nancy Devlin, and Ben van Hout
Summary: The 2017 English EQ-5D-5L value set differs substantially from the 1997 UK EQ-5D-3L value set recommended by NICE. Given the implications of using the 5L value set instead of the 3L value set, it is important to understand the reasons why this is. This paper explores the differences, and results suggest they are primarily caused by differences in the underlying preference data. Applying the 5L modelling methods to 3L valuation data would yield a different value set with different properties than the existing UK 3L value set. However, the modelling methods exert a greater magnitude of difference on the 5L values than on the 3L values. Results raise questions about the interpretation of the constant in value functions.
Discussant: David Epstein
Time & location: Thursday 11th January, 16:00, B104

OHE team members discussing others’ research and chairing sessions:

The Nutritional Impact of Price Promotions in Sugar Sweetened Beverages
Author: Toby Watt
Discussed by Grace Hampson, Chaired by Luke Munford, 10th January, 13:30, B103

The Effect of Acculturation on Immigrants’ Health Behaviour: Evidence from the United Kingdom
Author: Ekaterina Kuznetsova
Discussed by Luke Munford, Chaired by Yan Feng, 10th January, 14:35, B103

A Markov Model to Estimate the Cost-effectiveness of Interventions for Treatment of Chronic Venous Leg Ulcers
Author: David Epstein
Discussed by Lois Kim, Chaired by Patricia Cubi-Molla, 11th January, 09:00, B104

Real-world Evidence of the Effectiveness of Adjuvant Chemotherapy for Early Stage Breast Cancer from Scottish Routine Data
Author: Ewan Gray
Discussed by Rachel Meacock, Chaired by Paula Lorgelly, 11th January, 16:00, B200

Early Modelling Methods for Economic Evaluation of Diagnostic Technology: The Collective Experiences of the Diagnostic Evidence Co-operatives
Author: Lucy Abel
Discussed by Chris Sampson, Chaired by Kyriaki Giorgakoudi, 12th January, 09:30, B104

Impact of an Acute Health Shock on Lifestyles: Evidence from French Panel Data
Author: Antoine Marsaudon
Discussed by Patricia Cubi-Molla, Chaired by Mark Connolly, 12th January, 11:00, B103

Recycling Cost-Effectiveness models: How and Why?
Author: Anum Shaikh
Discussed by Emma McManus, Chaired by Chris Sampson, 12th January, 12:05, B104

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • January 2020

OHE at HESG Winter 2020

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!